Skip to Content

Bone Cancer Survivor Selected for SpaceX Flight

MONDAY, Feb. 22, 2021 -- Bone cancer survivor Hayley Arceneaux says her battle with the disease helped prepare her to serve as crew medical officer on a SpaceX flight later this year that is being used as a charitable fundraiser for St. Jude Children's Research Hospital.

Arceneaux is joining billionaire Jared Isaacman, who wants to raise $200 million for the hospital. He offered one seat on the SpaceX Dragon capsule to St. Jude, and there will be two yet-to-be-chosen contest winners, the Associated Press reported.

St. Jude selected Arceneaux, 29, to occupy its seat. She is a former patient who was hired as a physician assistant last spring. She will become the youngest American in space and also the first in space with a prosthesis. At age 10 years, Arceneaux had surgery at St. Jude to replace her knee and received a titanium rod in her left thigh bone.

"My battle with cancer really prepared me for space travel," Arceneaux told the AP. "It made me tough, and then also I think it really taught me to expect the unexpected and go along for the ride." Arceneaux said she wants to show her young patients and other cancer survivors that "the sky is not even the limit anymore," and she added that "it's going to mean so much to these kids to see a survivor in space."

Associated Press Article

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Liver Cancer Profile Differs in Black Patients With Hep C

THURSDAY, Feb. 25, 2021 -- Black patients with hepatitis C virus (HCV) infection develop hepatocellular carcinoma (HCC) at an earlier disease stage and have better liver function...

Mortality Gap Between Cancer, Heart Disease Narrowing for Women Younger Than 65

THURSDAY, Feb. 25, 2021 -- For women aged younger than 65 years, the mortality gap between cancer and heart disease is narrowing, according to a study published online Feb. 8 in...

Trial of Gene Therapy for Sickle Cell Disease Halted

TUESDAY, Feb. 23, 2021 -- A clinical trial of a new gene therapy for sickle cell disease that has shown promise has been halted after two participants were diagnosed with...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.